![Evaluating Ciprofloxacin Dosing for Pseudomonas aeruginosa Infection by Using Clinical Outcome-Based Monte Carlo Simulations | Antimicrobial Agents and Chemotherapy Evaluating Ciprofloxacin Dosing for Pseudomonas aeruginosa Infection by Using Clinical Outcome-Based Monte Carlo Simulations | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.49.10.4009-4014.2005/asset/cb2963d8-7cd2-45ac-9561-2b6c39033431/assets/graphic/zac0100553100002.jpeg)
Evaluating Ciprofloxacin Dosing for Pseudomonas aeruginosa Infection by Using Clinical Outcome-Based Monte Carlo Simulations | Antimicrobial Agents and Chemotherapy
![PDF) Evaluating Ciprofloxacin Dosing for Pseudomonas aeruginosa Infection by Using Clinical Outcome-Based Monte Carlo Simulations PDF) Evaluating Ciprofloxacin Dosing for Pseudomonas aeruginosa Infection by Using Clinical Outcome-Based Monte Carlo Simulations](https://i1.rgstatic.net/publication/7575591_Evaluating_Ciprofloxacin_Dosing_for_Pseudomonas_aeruginosa_Infection_by_Using_Clinical_Outcome-Based_Monte_Carlo_Simulations/links/0c9605296320275e25000000/largepreview.png)
PDF) Evaluating Ciprofloxacin Dosing for Pseudomonas aeruginosa Infection by Using Clinical Outcome-Based Monte Carlo Simulations
![Evaluating Ciprofloxacin Dosing for Pseudomonas aeruginosa Infection by Using Clinical Outcome-Based Monte Carlo Simulations | Antimicrobial Agents and Chemotherapy Evaluating Ciprofloxacin Dosing for Pseudomonas aeruginosa Infection by Using Clinical Outcome-Based Monte Carlo Simulations | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.49.10.4009-4014.2005/asset/8d87dac6-2c8c-4e30-8324-486e1eb813e8/assets/graphic/zac0100553100001.jpeg)
Evaluating Ciprofloxacin Dosing for Pseudomonas aeruginosa Infection by Using Clinical Outcome-Based Monte Carlo Simulations | Antimicrobial Agents and Chemotherapy
![Antibiotics | Free Full-Text | Thermal Shock and Ciprofloxacin Act Orthogonally on Pseudomonas aeruginosa Biofilms Antibiotics | Free Full-Text | Thermal Shock and Ciprofloxacin Act Orthogonally on Pseudomonas aeruginosa Biofilms](https://pub.mdpi-res.com/antibiotics/antibiotics-10-01017/article_deploy/html/images/antibiotics-10-01017-ag.png?1629544749)
Antibiotics | Free Full-Text | Thermal Shock and Ciprofloxacin Act Orthogonally on Pseudomonas aeruginosa Biofilms
Dose ranging and fractionation of intravenous ciprofloxacin against Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro model of infection. - Abstract - Europe PMC
![SciELO - Saúde Pública - Ceftriaxone and ciprofloxacin restriction in an intensive care unit: less incidence of Acinetobacter spp. and improved susceptibility of Pseudomonas aeruginosa Ceftriaxone and ciprofloxacin restriction in an intensive SciELO - Saúde Pública - Ceftriaxone and ciprofloxacin restriction in an intensive care unit: less incidence of Acinetobacter spp. and improved susceptibility of Pseudomonas aeruginosa Ceftriaxone and ciprofloxacin restriction in an intensive](https://www.scielosp.org/media/assets/rpsp/v30n6/a18tab03.jpg)
SciELO - Saúde Pública - Ceftriaxone and ciprofloxacin restriction in an intensive care unit: less incidence of Acinetobacter spp. and improved susceptibility of Pseudomonas aeruginosa Ceftriaxone and ciprofloxacin restriction in an intensive
![PDF] Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: Guidelines by the Spanish Society of Chemotherapy | Semantic Scholar PDF] Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: Guidelines by the Spanish Society of Chemotherapy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2745a0416a706e1fb678f75965101dcc74b43e17/13-Table4-1.png)
PDF] Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: Guidelines by the Spanish Society of Chemotherapy | Semantic Scholar
![Tolerability and Pharmacokinetic Properties of Ciprofloxacin Dry Powder for Inhalation in Patients With Cystic Fibrosis: A Phase I, Randomized, Dose-Escalation Study - ScienceDirect Tolerability and Pharmacokinetic Properties of Ciprofloxacin Dry Powder for Inhalation in Patients With Cystic Fibrosis: A Phase I, Randomized, Dose-Escalation Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0149291813008795-gr1.jpg)
Tolerability and Pharmacokinetic Properties of Ciprofloxacin Dry Powder for Inhalation in Patients With Cystic Fibrosis: A Phase I, Randomized, Dose-Escalation Study - ScienceDirect
![Oral ciprofloxacin treatment of Pseudomonas aeruginosa osteomyelitis | Antimicrobial Agents and Chemotherapy Oral ciprofloxacin treatment of Pseudomonas aeruginosa osteomyelitis | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/asset/0416cf29-0353-476c-b226-5a2c9985920d/aac.1990.34.issue-5.largecover.jpg)